Literature DB >> 9140097

Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses.

A Sjölander1, B van't Land, K Lövgren Bengtsson.   

Abstract

The immune stimulating complex (iscom) is built up by antigen, cholesterol, phospholipids, and adjuvant active Quillaja saponins. Previous studies have shown that iscoms containing Quil A (a semipurified preparation of saponins) efficiently induce antibody and cell-mediated immune responses. In this study, we demonstrate that iscoms containing a mixture of two purified low toxicity Quillaja saponin fractions (ISCOPREP 703) are able to upregulate both Th1-like and Th2-like immune responses. Thus, ovalbumin (OVA) iscoms induced higher levels of antigen-specific IgG1 and IgG2a antibodies and increased the production of both IFN-gamma and IL-4 compared with OVA administered without adjuvant. In contrast, OVA formulated in Al(OH)3 elicited IgG1 and IgE antibodies and primed spleen cells producing IL-4 and IL-10, suggesting the activation of primarily Th2-like cells. These findings underline that adjuvants are able to alter the character of immune responses and may be used to generate responses with desired properties.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140097     DOI: 10.1006/cimm.1997.1088

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

1.  The antimetastatic and immunomodulating activities of ginseng minor glycosides.

Authors:  A M Popov; L N Atopkina; N I Uvarova; G B Elyakov
Journal:  Dokl Biochem Biophys       Date:  2001 Sep-Oct       Impact factor: 0.788

2.  Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

Authors:  E J Verschoor; P Mooij; H Oostermeijer; M van der Kolk; P ten Haaft; B Verstrepen; Y Sun; B Morein; L Akerblom; D H Fuller; S W Barnett; J L Heeney
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.

Authors:  Neil C Robson; Helen Beacock-Sharp; Anne M Donachie; Allan McI Mowat
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

4.  Vaccine-induced antibodies linked to bovine neonatal pancytopenia (BNP) recognize cattle major histocompatibility complex class I (MHC I).

Authors:  Fabian Deutskens; Benjamin Lamp; Christiane M Riedel; Eveline Wentz; Günter Lochnit; Klaus Doll; Heinz-Jürgen Thiel; Till Rümenapf
Journal:  Vet Res       Date:  2011-08-30       Impact factor: 3.683

5.  Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy.

Authors:  Rachel Buglione-Corbett; Kimberly Pouliot; Robyn Marty-Roix; Kim West; Shixia Wang; Egil Lien; Shan Lu
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

6.  Low-molecular-weight polysaccharides from Agaricus blazei Murrill modulate the Th1 response in cancer immunity.

Authors:  Liyan Jiang; Zhipu Yu; Yu Lin; Liran Cui; Shujuan Yao; Liyan Lv; Jicheng Liu
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

7.  Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen.

Authors:  Jenny M Reimer; Karin H Karlsson; Karin Lövgren-Bengtsson; Sofia E Magnusson; Alexis Fuentes; Linda Stertman
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen.

Authors:  Ghalia Boubaker; Andrew Hemphill; Cristina Olivia Huber; Markus Spiliotis; Hamouda Babba; Bruno Gottstein
Journal:  PLoS Negl Trop Dis       Date:  2015-06-08

Review 9.  A Systematic Review of Recent Advances in Equine Influenza Vaccination.

Authors:  Romain Paillot
Journal:  Vaccines (Basel)       Date:  2014-11-14

10.  A polysaccharide isolated from Agaricus blazei Murill (ABP-AW1) as a potential Th1 immunity-stimulating adjuvant.

Authors:  Liran Cui; Yongxu Sun; Hao Xu; Huiyu Xu; Huan Cong; Jicheng Liu
Journal:  Oncol Lett       Date:  2013-07-23       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.